Characterization of patients operated on with a diagnosis of skin cancer over a period of 5 years

Authors

Keywords:

basal cell carcinoma, minor surgical procedures, skin cancer.

Abstract

Introduction: Skin cancer is one of the most common types of cancer in the world, and it is estimated that the risk of developing it increases from 1 to 5 throughout life. Its incidence has increased considerably in recent decades.
Objective: To characterize the patients operated with skin cancer in the minor outpatient surgery clinic.
Methods: A cross-sectional descriptive observational study was conducted in the population attended in the outpatient minor surgery consultation belonging to the Lawton Teaching Polyclinic, located in Diez de Octubre municipality of the province of Havana between the years 2018 and 2022. The following variables were used: sex, age, skin complexion, lesion location and histological type. Frequency analysis was performed.
Results: A predominance of females was observed with 57.22%, predominating between the ages of 65 - 76 years of age, mostly of white complexion. There was an increase in the incidence during the year 2021 with 29%. The most frequent location was on the face with 27.84% of the total. The definitive diagnosis according to the biopsy results was solid basal carcinoma with 36.69%.
Conclusions: In the series of cases studied, the female sex, the elderly, white skin predominate, and solid basal carcinoma is more frequently present.

Downloads

Download data is not yet available.

References

1. Avalos N, Sepúlveda C. Pacientes añosos con cáncer de piel no melanoma: consecuencias del tratamiento tardío. Piel (Barc). 2019 [acceso: 23/07/2023]; 34(8):[aprox. 4 d.]. Disponible en: https://www.clinicalkey.es/#!/content/playContent/1-s2.0-S0213925118303265?returnurl=null&referrer=null

2. Molina Linares II, Mora Marcial GR, González Pérez S, Morales Rodríguez CM, Ferrer Calero OL, Broche Manso Y. Características clínico-epidemiológicas de pacientes con lesiones malignas en la piel. Medicentro Electrónica. 2020 [acceso: 23/07/2023]; 24(2):305-19. Disponible en: http://scielo.sld.cu/scielo.php?script=sci_arttext&pid=S1029-30432020000200305&lng=es

3. Veja Abascal J, Álvarez Fernández A, Ventura Nieves K, Fernández Hidalgo A, Nodal Trujillo S. Tratamiento con HeberFERON® del carcinoma basocelular en la Atención Primaria de Salud en Cuba. Rev Cubana Med Gen Integr. 2021 [acceso: 23/07/2023]; 37(2):e1340. Disponible en: http://scielo.sld.cu/scielo.php?script=sci_arttext&pid=S0864-21252021000200020&lng=es.

4. Nazco Torres J, Labrador Díaz JF, Castro Crespo D, Aguiar Ferro Y, Rodríguez Hernández Y. Tratamiento de tumores de piel con SENSUS SRT-100TM en el Centro Oncológico Pinareño. Rev Ciencias Médicas. 2019 [acceso: 23/07/2023]; 23(6):817-26. Disponible en: http://scielo.sld.cu/scielo.php?script=sci_arttext&pid=S1561-31942019000600817&lng=es

5. Batista Peña M, Arzuaga Hernández E, González Piloto S, Pérez Polanco ES. Tratamiento no quirúrgico, quirúrgico y reconstructivo del carcinoma basal de párpados. Rev Cubana Oftalmol. 2021 [acceso: 23/07/2023]; 34(3):e1066. Disponible en: http://scielo.sld.cu/scielo.php?script=sci_arttext&pid=S0864-21762021000300015&lng=es

6. Vázquez Blanco E, Domínguez Moralobo RA, Zamora León I, Valerino Guzmán E, Vázquez Ortíz HJ. Caracterización clínica y epidemiológica del carcinoma basocelular en el Hospital Celia Sánchez Manduley, 2017- 2019. Rev Ciencias Médicas. 2021 [acceso: 23/07/2023]; 25(5):e5053. Disponible en: http://scielo.sld.cu/scielo.php?script=sci_arttext&pid=S1561-31942021000500008&lng=es

7. Cabrera Naranjo DL, Sánchez Linares V, Román Simón M, Rondón Madrigal E, Bello Rivero I. Carcinoma basocelular tratado con HeberFERON, seguimiento clínico, histológico y ecográfico. Reporte de caso. Gac Méd Espirit. 2020 [acceso: 23/07/2023]; 22(3):119-28. Disponible en: http://scielo.sld.cu/scielo.php?script=sci_arttext&pid=S1608-89212020000300119&lng=es

8. Asociación Médica Mundial. Declaración de Helsinki de la AMM - Principios éticos para las investigaciones médicas en seres humanos. Fortaleza: 64ª Asamblea General; 2013. [acceso: 23/07/2023]. Disponible en: https://www.wma.net/es/policies-post/declaracion-de-helsinki-de-la-amm-principios-eticos-para-las-investigaciones-medicas-en-seres-humanos/

9. Sánchez Linares V, Cifuentes Suarez JP, Martínez Cuervo JJ, Román Simón M, Pérez García C, Bello Rivero I. Carcinoma basocelular del rostro tratados con HeberFERON. Gac Méd Espirit. 2019 [acceso: 23/07/2023]; 21(2):87-97. Disponible en: http://scielo.sld.cu/pdf/gme/v21n2/1608-8921-gme-21-02-87.pdf

10. Sociedad Española de Oncología Médica. Márquez Rodas I. Melanoma; Madrid: SEOM. 2020. [acceso: 23/07/2023]. Disponible en: https://seom.org/info-sobre-el-cancer/melanoma?showall=1

11. Martín Pozo Y, Apolinario Castillo EC, Pérez Fleites D, Betancourt Pérez A, Alba Castellanos L, González Rodríguez R. Relación clínica-dermatoscópica-histológica de lesiones pigmentadas de piel sugestiva de melanoma. Acta méd centro. 2022 [acceso: 23/07/2023]; 16(3):488-503. Disponible en: http://scielo.sld.cu/scielo.php?script=sci_arttext&pid=S2709-79272022000300488&lng=es

12. Anderson Vildósola J, Hernández Martín A. Trastornos de la pigmentación: lentigos, nevus y melanoma. Fotoprotección. Pediatr Integral. 2021 [acceso: 23/07/2023]; 25(4):194-200. Disponible en: https://www.pediatriaintegral.es/publicacion-2021-06/trastornos-de-lapigmentacion-lentigos-nevus-y-melanoma-fotoproteccion-2021/

13. Hornillos de Villota M, Pozo Kreilinger JJ, del Castillo Pardo de Vera JL, Cebrián Carretero JL. Carcinoma basoescamoso diseminado. A propósito de un caso. Rev Esp Cirug Oral y Maxilofac. 2021 [acceso: 23/07/2023]; 43(4):166-9. Disponible en: http://scielo.isciii.es/scielo.php?script=sci_arttext&pid=S1130-05582021000400008&lng=es

14. Dirección de Registros Médicos y Estadísticas de Salud. Anuario Estadístico de Salud 2019. La Habana: MINSAP; 2020. [acceso: 23/07/2023]. Disponible en: https://temas.sld.cu/estadisticassalud/2021/08/11/anuarioestadistico-de-salud-2020/

15. Álvarez Lobaina A, Mir Espinosa YL. Tratamiento y supervivencia de pacientes con melanoma en el Instituto Nacional de Oncología y Radiobiología. Rev haban cienc méd. 2021 [acceso: 23/07/2023]; 20(6):e3530. Disponible en: http://www.revhabanera.sld.cu/index.php/rhab/article/view/3530

16. Curbelo Alonso M, Díaz Leonard D, Bernárdez Cruz Y, Suárez Rodríguez AE. Cáncer de piel no melanoma y radiaciones ultravioletas. Folia Dermatológica Cubana. 2018 [acceso: 23/07/2023]; 12(1):[aprox. 9p]. Disponible en: http://www.revfdc.sld.cu/index.php/fdc/article/vie w/114/119

17. Curbelo Alonso M, Iglesias León M. Diagnóstico sobre el abordaje del tema prevención del cáncer cutáneo en la asignatura Dermatología para la formación del médico general. Medisur. 2021 [acceso: 23/07/2023]; 19(2):329-337. Disponible en: http://scielo.sld.cu/scielo.php?script=sci_arttext&pid=S1727-897X2021000200329&lng=es

Downloads

Published

2024-05-24

How to Cite

1.
Bejerano Durán R, Armada Capote A. Characterization of patients operated on with a diagnosis of skin cancer over a period of 5 years. Rev Cubana Med Milit [Internet]. 2024 May 24 [cited 2025 Apr. 3];53(2):e024030115. Available from: https://revmedmilitar.sld.cu/index.php/mil/article/view/30115

Issue

Vol. 53 No. 2 (2024): April - June

Section

Clinical Practice Article

License

Authors who have publications with this Journal accept the following terms:

  • The authors will retain their copyright and guarantee the Journal the right of first publication of their work, which will simultaneously be subject to the Creative Commons Attribution License. The content presented here can be shared, copied and redistributed in any medium or format; Can be adapted, remixed, transformed or created from the material, using the following terms: Attribution (giving appropriate credit to the work, providing a link to the license, and indicating if changes have been made); non-commercial (you cannot use the material for commercial purposes) and share-alike (if you remix, transform or create new material from this work, you can distribute your contribution as long as you use the same license as the original work).
  • The authors may adopt other non-exclusive license agreements for the distribution of the published version of the work (for example: depositing it in an institutional electronic archive or publishing it in a monographic volume) as long as the initial publication in this Journal is indicated.
  • Authors are allowed and recommended to disseminate their work through the Internet (e.g., in institutional electronic archives or on their website) before and during the submission process, which can produce interesting exchanges and increase citations. of the published work.